Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,722,270
  • Shares Outstanding, K 36,047
  • Annual Sales, $ 12,930 K
  • Annual Income, $ -98,420 K
  • 60-Month Beta 1.95
  • Price/Sales 197.27
  • Price/Cash Flow N/A
  • Price/Book 8.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -1.22
  • Number of Estimates 8
  • High Estimate -1.17
  • Low Estimate -1.30
  • Prior Year -0.94
  • Growth Rate Est. (year over year) -29.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.11 +37.04%
on 04/30/19
76.69 -1.53%
on 05/16/19
+12.25 (+19.36%)
since 04/18/19
3-Month
55.11 +37.04%
on 04/30/19
80.00 -5.60%
on 03/18/19
-0.02 (-0.03%)
since 02/21/19
52-Week
28.50 +164.98%
on 10/22/18
80.00 -5.60%
on 03/18/19
+39.72 (+110.95%)
since 05/21/18

Most Recent Stories

More News
Interesting MRTX Put And Call Options For July 19th

Investors in Mirati Therapeutics Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRTX options...

MRTX : 75.52 (+6.76%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (IRWD , CHRS , MRTX, MGNX , RTRX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

IRWD : 11.51 (+3.23%)
CHRS : 19.78 (+3.83%)
MRTX : 75.52 (+6.76%)
Macrogenics Inc has the Best Relative Performance in the Biotechnology Industry (MGNX , MRTX, EPZM , AGIO , FLXN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

MGNX : 18.74 (+2.74%)
MRTX : 75.52 (+6.76%)
EPZM : 12.58 (+10.06%)
Mirati Therapeut Set to Possibly Pullback After Yesterday's Rally of 17.38%

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $72.95 to a high of $75.85. Yesterday, the shares gained 17.4%, which took the trading range above the 3-day high...

MRTX : 75.52 (+6.76%)
Options Traders Expect Huge Moves in Mirati Therapeutics (MRTX) Stock

Investors need to pay close attention to Mirati Therapeutics (MRTX) stock based on the movements in the options market lately.

MRTX : 75.52 (+6.76%)
Shares of Ptc Therapeutics Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PTCT , AMAG , PRTA , GBT , MRTX)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

PTCT : 40.06 (+7.14%)
PRTA : 9.52 (+2.59%)
AMAG : 10.22 (+1.49%)
MRTX : 75.52 (+6.76%)
Market Trends Toward New Normal in The J. M. Smucker, Zendesk, Sterling Construction, and Mirati Therapeutics -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of The J. M. Smucker Company...

ZEN : 88.18 (+0.98%)
SJM : 126.69 (-0.55%)
STRL : 12.22 (+1.16%)
MRTX : 75.52 (+6.76%)
Mirati Therapeut Falls 3.38% on Heavy Volume: Watch For Potential Rebound

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $59.03 to a high of $60.93. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of...

MRTX : 75.52 (+6.76%)
Mirati: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Monday reported a loss of $40.9 million in its first quarter.

MRTX : 75.52 (+6.76%)
After Yesterday's Decline of 3.27%, Mirati Therapeut Offers Investors Better Value

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $63.87 to a high of $65.60. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of...

MRTX : 75.52 (+6.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MRTX with:

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

2nd Resistance Point 78.79
1st Resistance Point 77.15
Last Price 75.52
1st Support Level 72.44
2nd Support Level 69.37

See More

52-Week High 80.00
Last Price 75.52
Fibonacci 61.8% 60.33
Fibonacci 50% 54.25
Fibonacci 38.2% 48.17
52-Week Low 28.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar